Welcome to LookChem.com Sign In|Join Free
  • or
ETHYL 4-(1H-PYRROL-1-YL)BENZOATE, also known as ethyl 4-(1H-pyrrol-1-yl)benzoate, is a synthetic ester with the molecular formula C15H13NO2. It belongs to the class of organic compounds known as benzoic acid esters and features a pyrrole ring, which imparts unique properties to this chemical compound. This makes it a versatile building block in the pharmaceutical industry for the synthesis of various drugs and active pharmaceutical ingredients.

5044-37-1

Post Buying Request

5044-37-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5044-37-1 Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 4-(1H-PYRROL-1-YL)BENZOATE is used as a building block for the synthesis of various drugs and active pharmaceutical ingredients due to its unique properties and the presence of a pyrrole ring, which is beneficial in the development of pharmaceutical compounds.
Used in Cosmetics Industry:
ETHYL 4-(1H-PYRROL-1-YL)BENZOATE is used as a fragrance and flavoring agent in the cosmetics industry, where its unique properties contribute to the creation of various scents and flavors.
Used in Food Industry:
Similarly, in the food industry, ETHYL 4-(1H-PYRROL-1-YL)BENZOATE is utilized as a flavoring agent to enhance the taste and aroma of various food products.
Safety Precautions:
It is important to handle ETHYL 4-(1H-PYRROL-1-YL)BENZOATE with caution and follow proper safety protocols due to its potential hazards, ensuring the safety of both individuals and the environment.

Check Digit Verification of cas no

The CAS Registry Mumber 5044-37-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,4 and 4 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 5044-37:
(6*5)+(5*0)+(4*4)+(3*4)+(2*3)+(1*7)=71
71 % 10 = 1
So 5044-37-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO2/c1-2-16-13(15)11-5-7-12(8-6-11)14-9-3-4-10-14/h3-10H,2H2,1H3

5044-37-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H32267)  Ethyl 4-(1-pyrrolyl)benzoate, 97%   

  • 5044-37-1

  • 1g

  • 289.0CNY

  • Detail
  • Alfa Aesar

  • (H32267)  Ethyl 4-(1-pyrrolyl)benzoate, 97%   

  • 5044-37-1

  • 5g

  • 1150.0CNY

  • Detail

5044-37-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4-pyrrol-1-ylbenzoate

1.2 Other means of identification

Product number -
Other names ethyl 4-(1H-pyrrol-1-yl)benzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5044-37-1 SDS

5044-37-1Relevant academic research and scientific papers

Near-infrared fluorescent compound with AIE performance as well as preparation method and application thereof

-

Paragraph 0095; 0103; 0104, (2018/12/14)

The invention relates to the technical field of organic synthesis and novel materials and particularly relates to a near-infrared fluorescent compound with AIE performance as well as a preparation method and application thereof. According to the fluoresce

Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors

Joshi, Shrinivas D.,Dixit, Sheshagiri R.,Kulkarni, Venkatarao H.,Lherbet, Christian,Nadagouda, Mallikarjuna N.,Aminabhavi, Tejraj M.

, p. 286 - 297 (2016/12/09)

In efforts to develop lead anti-TB compounds, a novel series of 19 pyrrolyl benzohydrazides were synthesized and screened to target enoyl-ACP reductase enzyme, which is one of the important enzymes involved in type II fatty acid biosynthetic pathway of M.

Pd/Cu-catalyzed dual C-H bond carbonylation towards the synthesis of fluorazones

Liao, Fan,Shi, Renyi,Sha, Yuchen,Xia, Jianhui,Liao, Weilin,Lei, Aiwen

supporting information, p. 4354 - 4357 (2017/04/21)

Pd/Cu catalyzed oxidative dual C-H bond activation/carbonylation still remains a great challenge due to the generation of by-products via C-C bond formation. Herein we developed a straightforward Pd/Cu-catalyzed oxidative dual C-H bond carbonylation process to access biologically and pharmaceutically important fluorazones from easily available N-aryl pyrroles and CO. A wide range of functional groups were well tolerated in this transformation, and O2 could be utilized as the only terminal oxidant to promote the oxidative carbonylation process.

Electronically Strongly Coupled Divinylheterocyclic-Bridged Diruthenium Complexes

Pfaff, Ulrike,Hildebrandt, Alexander,Korb, Marcus,O?wald, Steffen,Linseis, Michael,Schreiter, Katja,Spange, Stefan,Winter, Rainer F.,Lang, Heinrich

, p. 783 - 801 (2016/01/15)

Complexes [{Ru(CO)Cl(PiPr3)2}2(μ-2,5-(CH=CH)2-cC4H2E] (E=NR; R=C6H4-4-NMe2 (10a), C6H4-4-OMe (10b), C6H4-4-Me (10c), C6H5 (10d), C6H4-4-CO2Et (10e), C6H4-4-NO2 (10f), C6H3-3,5-(CF3)2 (10g), CH3 (11); E=O (12), S (13)) are discussed. The solid state structures of four alkynes and two complexes are reported. (Spectro)electrochemical studies show a moderate influence of the nature of the heteroatom and the electron-donating or -withdrawing substituents R in 10a-g on the electrochemical and spectroscopic properties. The CVs display two consecutive one-electron redox events with ΔE°′=350-495 mV. A linear relationship between ΔE°′ and the σp Hammett constant for 10a-f was found. IR, UV/Vis/NIR and EPR studies for 10+-13+ confirm full charge delocalization over the {Ru}CH=CH-heterocycle-CH=CH{Ru} backbone, classifying them as Class III systems according to the Robin and Day classification. DFT-optimized structures of the neutral complexes agree well with the experimental ones and provide insight into the structural consequences of stepwise oxidations.

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 0563; 0564, (2016/09/26)

Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.

Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes

Joshi, Shrinivas D.,Kumar, Devendra,Dixit, Sheshagiri R.,Tigadi, Nageshwar,More, Uttam A.,Lherbet, Christian,Aminabhavi, Tejraj M.,Yang, Kap Seung

, p. 21 - 39 (2016/08/19)

Novel pyrrolyl hydrazones and their copper complexes have been synthesized and characterized using analytical and spectral techniques to show the tetrahedral geometry for Cu(II) complexes. Biological activities of hydrazones have been assessed to understand the role of metal ion on their biological activity and the effect of pyrrolyl hydrazones. In?vitro antitubercular activity against Mycobacterium tuberculosis of the metal complexes (13b and 13r) exhibited the highest antitubercular activity that are quite close to rifampicin (0.4?μg/mL), giving a MIC of 0.8?μg/mL. All other compounds showed good activity with the MIC values ranging from 1.6 to 100?μg/mL. A comparative study of inhibition values of the ligands and their complexes showed higher antimicrobial activity of the complexes than the ligands. Some compounds have a good activity against InhA and in particular, compounds 12r, 13b and 13r exhibited more than 60% binding with the enzyme even at 5?μM (exhibited good IC50 upto 2.4?μM). Most of the active molecules have a very less cytotoxicity against the human lung cancer cell-line A549. The docking and 3D-QSAR studies have been carried out to provide some insights into the mechanism of action for this class of compounds.

Benzoic acid derivatives with improved antifungal activity: Design, synthesis, structure-activity relationship (SAR) and CYP53 docking studies

Berne, Sabina,Kova?i?, Lidija,Sova, Matej,Kra?evec, Nada,Gobec, Stanislav,Kri?aj, Igor,Komel, Radovan

, p. 4264 - 4276 (2015/08/03)

Previously, we identified CYP53 as a fungal-specific target of natural phenolic antifungal compounds and discovered several inhibitors with antifungal properties. In this study, we performed similarity-based virtual screening and synthesis to obtain benzo

Synthesis and antimicrobial activities of some novel pyrrolyl pyrrolidine derivatives

Joshi, Shrinivas D.,Dixit, Sheshagiri R.,Sanjay, Khadela,Kulkarni, Venkatrao H.

, p. 61 - 64 (2019/01/21)

A series of N'-(4-(1H-pyrrol-1-yl)benzoyl)-5-oxo-1-substituted phenylpyrrolidine-3- carbohydrazides (VIIa-f) was synthesized by the reaction of 5-oxo-1-substituted phenylpyrrolidine-3-carboxylic acids (VIa-f) with 4-(1H-pyrrol-1-yl)benzoic acid hydrazide

Synthesis, antibacterial and antitubercular activities of novel n1- [2-(substituted phenylamino) acetyl]-4-(1H-pyrrol-1-yl)- benzohydrazide derivatives

Pradeep Kumar,Joshi, Shrinivas D.,Dixit, Sheshagiri R.,Kulkarni

, p. 37 - 44 (2019/01/21)

With an objective of synthesizing potent antitubercular agents, here we have synthesized some novel pyrrole derivatives. In this ethyl-4-pyrrol-1-yl-benzoate (I) was synthesized by the reaction of benzocaine with 2,5-dimethoxytetrahydrofuran in the presen

Synthesis, characterization, biological activity, and 3D-QSAR studies on some novel class of pyrrole derivatives as antitubercular agents

Joshi, Shrinivas D.,More, Uttam A.,Dixit, Sheshagiri R.,Korat, Haresh H.,Aminabhavi, Tejraj M.,Badiger, Aravind M.

, p. 1123 - 1147 (2014/03/21)

A new series of pyrrole derivatives have been designed, synthesized, and their structures have been elucidated along with the evaluation of antitubercular activity against Mycobacterium tuberculosis H37Rv using the microplate alamar blue assay method and antibacterial activity against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, and Escherichia coli by broth micro-dilution assay method. Structural activity relationships and 3D-QSAR analysis have been carried out by Topomer Comparative Molecular Field Analysis (CoMFA). Training set of 42 and test set of 8 active compounds were used to develop the method that showed cross-validated correlation coefficient (q 2) of 0.815, standard error of prediction of 0.36, non-cross-validated correlation coefficient (r 2) of 0.973, and standard error of estimate of 0.14 with six components. Graphical Abstract: Synthesis; spectral and 3D-QSAR studies; and antibacterial, antitubercular, and cytotoxic activities of a novel series of pyrrole derivatives are described.[Figure not available: see fulltext.]

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5044-37-1